Alnylam Pharmaceuticals $303.64 (+11.06, 3.78%)

Buy or Sell Report NASDAQ

Analysis for Alnylam Pharmaceuticals

Summary
LONGBUY: Best moves 22 which gains 1715.97, return on capital invested 2.88%
Details
Systematic Stock Control...Version 3.1.2.13084: x64 MS Windows
Copyright© Graham Armstrong, 1997, 2003, 2021-2026

Report file for: Alnylam Pharmaceuticals
Published on: 4 June 2026 20:37:45 -06:00

                                 Raw Data Range

  Hi-Low         First          Last        Lowest       Highest
     252      305.3100      303.6400      284.8400      491.2200

                       Hi-Low Time taken: 00:00.0000048

===============================================================================
                               Maximum Reduction

              Polynomials 2, Moves 3, Sigma 10.0546, Reduction 98

                              Buy or Sell Summary

    Move     Alpha    Sigma    Investment      Return     Mean    Percent    Periods
       1    100.00     0.00             0           0     0.00       0.00          0
       2     66.67    41.78      47506.51      293.59     2.31       0.62        127
       3     50.00     9.55      45598.51      147.66     1.22       0.32        121
       4     40.00     2.77      45993.81      -46.97    -0.39      -0.10        121
       5     33.33     1.20      48456.44     -491.49    -3.87      -1.01        127
       6     28.57     0.66      54830.38     -520.11    -3.69      -0.95        141
       7     25.00     0.40      56989.83     -151.16    -1.02      -0.27        148
       8     22.22     0.27      48407.07     -431.85    -3.35      -0.89        129
       9     20.00     0.22      46116.25     -449.51    -3.68      -0.97        122
      10     18.18     0.20      49131.82      -748.6    -5.71      -1.52        131
      11     16.67     0.19      50897.55     -709.73    -5.34      -1.39        133
      12     15.38     0.19      56815.69     -202.71    -1.37      -0.36        148
      13     14.29     0.19      58819.63     -138.19    -0.90      -0.23        153
      14     13.33     0.18      62090.02     -323.61    -1.99      -0.52        163
      15     12.50     0.16      64387.19     -539.35    -3.17      -0.84        170
      16     11.76     0.15      64132.18    -1094.59    -6.48      -1.71        169
      17     11.11     0.13      64107.55    -1407.61    -8.38      -2.20        168
      18     10.53     0.11       60644.9     -643.55    -4.00      -1.06        161
      19     10.00     0.10      51167.71      -147.6    -1.09      -0.29        136
      20      9.52     0.08      48827.33        1.87     0.01       0.00        131
      21      9.09     0.07      50698.29      119.39     0.88       0.24        136
      22      8.70     0.07      59580.67     1715.97    10.86       2.88        158
      23      8.33     0.06      60044.59     1620.46    10.19       2.70        159
      24      8.00     0.05      62407.72      1705.5    10.59       2.73        161
      25      7.69     0.05      63641.76     1640.28    10.00       2.58        164

  LONGBUY: Best moves 22 which gains 1715.97, return on capital invested 2.88%

Guidance is to LONGBUY, Last Effect 303.64, minimum underlying current price 10

    Guidance is to LONGBUY, Average Return 10.86%, minimum average return 5%

Guidance is to LONGBUY, Invested Percentage 62.7%, minimum invested periods percentage 30%

                      Overall Time taken: 00:00.0232351


/...End of report

Casting Forward Corporation, trading as Scientific Decisions Consultants
Address: 1322 18 Avenue Northwest, Calgary, Alberta T2M 0W4, Canada
Telephone: +1 (587) 885 3191
Email: shares@scidec.net
Website: https://ssc.castfwd.com/